In new re­search pa­per, No­var­tis out­lines how an old SMA pro­gram could al­ter the course of Hunt­ing­ton's

As ex­per­i­men­tal treat­ments for Hunt­ing­ton’s dis­ease con­tin­ue to suf­fer set­backs, No­var­tis is out­lin­ing a plan for a re­pur­posed SMA drug it hopes can break phar­ma …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER